Interestingly, GMSCs promote IL-2 production; detailed mechanisms are unclear, but this has therapeutic implications, since recent studies have indicated low doses of IL-2 can treat several immunological diseases, including GVHD (37, 38). This evidence concerns the gene IL2 and graft versus host disease.